Edward F Fritsch

7PUBLICATIONS
40CO-AUTHORS
Predictive and prognostic markersMolecular targetsMedical molecular engineering of nucleic acids and proteinsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Oct 14, 2026
Personalized neoantigen-targeting cancer vaccines in ovarian cancer: a phase 1 trial.

|Mar 12, 2026
Clinical development of cancer vaccines.

John B Haanen, Ton N M Schumacher, Jonathan C Kagan

|Feb 05, 2025
A neoantigen vaccine generates antitumour immunity in renal cell carcinoma.

David A Braun, Giorgia Moranzoni, Vipheaviny Chea

|Apr 01, 2024
Personalized Cancer Vaccines Directed against Tumor Mutations: Building Evidence from Mice to Humans.

Edward F Fritsch, Patrick A Ott

|Jan 22, 2021
Personal neoantigen vaccines induce persistent memory T cell responses and epitope spreading in patients with melanoma.

Zhuting Hu, Donna E Leet, Rosa L Allesøe

Pageof 2

Frequent Collaborators

4 joint publications

Patrick A Ott

3 joint publications

Kenneth J Livak

3 joint publications

Catherine J Wu

2 joint publications

Gad Getz